The knockdown of endogenous replication factor C4 decreases the growth and enhances the chemosensitivity of hepatocellular carcinoma cells

Liver International

Volumn 29, Issue 1, 2009, Pages 55-62

  Arai, Masaaki ^a   Kondoh, Nobuo ^a,b   Imazeki, Nobuo ^a   Hada, Akiyuki ^a   Hatsuse, Kazuo ^a   Matsubara, Osamu ^a   Yamamoto, Mikio ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b ASAHI UNIVERSITY   (Japan)

Author keywords

cDNA microarray; DNA checkpoint; Hepatocellular carcinoma (HCC); Replication factor C4 (RFC4); Small interfering RNA (siRNA)

Indexed keywords

CAMPTOTHECIN; DOXORUBICIN; REPLICATION FACTOR C; REPLICATION FACTOR C4; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN HEPG2; CHEMOSENSITIVITY; CONTROLLED STUDY; DNA DAMAGE; DNA MICROARRAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE IDENTIFICATION; GENE SILENCING; GENETIC SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; DNA PRIMERS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPLICATION PROTEIN C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELLS, CULTURED;

EID: 57749191742     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01792.x     Document Type: Article

References (32)

1. Mann CD, Neal CP, Garcea G, et al. Prognostic molecular markers in hepatocellular carcinoma: A systematic review. Eur J Cancer 2007; 43: 979-92.
2. Kubo Y, Okuda K, Hashimoto M, et al. Antibody to hepatitis B core antigen in patients with hepatocellular carcinoma. Gastroenterology 1977; 72: 1217-20.
3. Sbolli G, Zanetti AR, Tanzi E, et al. Serum antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. J Med Virol 1990; 30: 230-2.
4. Kondoh N, Wakatsuki T, Ryo A, et al. Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res 1999; 59: 4990-6.
5. Shuda M, Kondoh N, Tanaka K, et al. Enhanced expression of translation factor mRNAs in hepatocellular carcinoma. Anticancer Res 2000; 20: 2489-94.
6. Tanaka K, Kondoh N, Shuda M, et al. Enhanced expression of mRNAs of antisecretory factor-1, gp96, DAD1 and CDC34 in human hepatocellular carcinomas. Biochim Biophys Acta 2001; 1536: 1-12.
7. Shuda M, Kondoh N, Imazeki N, et al. Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: A possible involvement of the ER stress pathway in hepatocarcinogenesis. J Hepatol 2003; 38: 605-14.
8. Kondoh N, Hada A, Ryo A, et al. Activation of galectin-1 gene in human hepatocellular carcinoma involves methylation-sensitive complex formations at the transcriptional upstream and downstream elements. Int J Oncol 2003; 23: 1575-83.
9. Arai M, Kondoh N, Imazeki N, et al. Transformation-associated gene regulation by ATF6alpha during hepatocarcinogenesis. FEBS Lett 2006; 580: 184-90.
10. Kondoh N, Imazeki N, Arai M, et al. Activation of a system A amino acid transporter, ATA1/SLC38A1, in human hepatocellular carcinoma and preneoplastic liver tissues. Int J Oncol 2007; 31: 81-7.
11. Noskov V, Maki S, Kawasaki Y, et al. The RFC2 gene encoding a subunit of replication factor C of Saccharomyces cerevisiae. Nucleic Acids Res 1994; 22: 1527-35.
12. Lee YC, Pan HW, Peng SY, et al. Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma. Eur J Cancer 2007; 43: 736-44.
13. Koide N, Hada H, Shinji T, et al. Expression of the midkine gene in human hepatocellular carcinomas. Hepatogastroenterology 1999; 46: 3189-96.
14. Yoon SY, Kim JM, Oh JH, et al. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags. Int J Oncol 2006; 29: 315-27.
15. Lee KW, Ko BC, Jiang Z, et al. Overexpression of aldose reductase in liver cancers may contribute to drug resistance. Anticancer Drugs 2001; 12: 129-32.
16. Fiegel HC, Gluer S, Roth B, et al. Stem-like cells in human hepatoblastoma. J Histochem Cytochem 2004; 52: 1495-501.
17. Cui JQ, Shi YF, Zhou HJ. Expression of RFC2 and PCNA in different gestational trophoblastic diseases. Ai Zheng 2004; 23: 196-200.
18. Noskov VN, Araki H, Sugino A. The RFC2 gene, encoding the third-largest subunit of the replication factor C complex, is required for an S-phase checkpoint in Saccharomyces cerevisiae. Mol Cell Biol 1998; 18: 4914-23.
19. Oancea M, Mazumder S, Crosby ME, et al. Apoptosis assays. Methods Mol Med 2006; 129: 279-90.
20. Okabe H, Satoh S, Kato T, et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: Identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 2001; 61: 2129-37.
21. Iizuka N, Oka M, Yamada-Okabe H, et al. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res 2002; 62: 3939-44.
22. Cullmann G, Fien K, Kobayashi R, et al. Characterization of the five replication factor C genes of Saccharomyces cerevisiae. Mol Cell Biol 1995; 15: 4661-71.
23. Sugimoto K, Shimomura T, Hashimoto K, et al. Rfc5, a small subunit of replication factor C complex, couples DNA replication and mitosis in budding yeast. Proc Natl Acad Sci USA 1996; 93: 7048-52.
24. Sugimoto K, Ando S, Shimomura T, et al. Rfc5, a replication factor C component, is required for regulation of Rad53 protein kinase in the yeast checkpoint pathway. Mol Cell Biol 1997; 17: 5905-14.
25. Kim HS, Brill SJ. Rfc4 interacts with Rpa1 and is required for both DNA replication and DNA damage checkpoints in Saccharomyces cerevisiae. Mol Cell Biol 2001; 21: 3725-37.
26. Mossi R, Hubscher U. Clamping down on clamps and clamp loaders -the eukaryotic replication factor C. Eur J Biochem 1998; 254: 209-16.
27. Flohr T, Dai JC, Buttner J, et al. Detection of mutations in the DNA polymerase delta gene of human sporadic colorectal cancers and colon cancer cell lines. Int J Cancer 1999; 80: 919-29.
28. Goldsby RE, Hays LE, Chen X, et al. High incidence of epithelial cancers in mice deficient for DNA polymerase delta proofreading. Proc Natl Acad Sci USA 2002; 99: 15560-5.
29. Taniai M, Tomimatsu M, Okuda H, et al. Immunohistochemical detection of proliferating cell nuclear antigen in hepatocellular carcinoma: relationship to histological grade. J Gastroenterol Hepatol 1993; 8: 420-5.
30. Chaib H, Cockrell EK, Rubin MA, et al. Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis. Neoplasia 2001; 3: 43-52.
31. Narayan G, Bourdon V, Chaganti S, et al. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: Identification of candidate amplified and overexpressed genes. Genes Chromosomes Cancer 2007; 46: 373-84.
32. Slebos RJ, Yi Y, Ely K, et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res 2006; 12: 701-9.